Cue Biopharma (CUE) EPS (Diluted) (2021 - 2025)
Cue Biopharma (CUE) EPS (Diluted) (2021 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Diluted) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.83 Bn | 130.98 Bn | 2.84 Bn | 4.31 |
| 2 | Regeneron Pharmaceuticals | 85.79 Bn | 77.79 Bn | 3.93 Bn | 12.23 |
| 3 | Argenx Se | 64.95 Bn | 59.77 Bn | 1.37 Bn | 7.33 |
| 4 | Moderna | 58.59 Bn | 53.46 Bn | 52.00 Mn | -1.96 |
| 5 | BeOne Medicines | 41.93 Bn | 36.83 Bn | 1.53 Bn | 2.05 |
| 6 | Alnylam Pharmaceuticals | 31.52 Bn | 28.21 Bn | 992.69 Mn | 1.19 |
| 7 | BioNTech SE | 27.98 Bn | 9.58 Bn | 668.28 Mn | -0.72 |
| 8 | Insmed | 27.42 Bn | 26.26 Bn | 358.27 Mn | -0.06 |
| 9 | Royalty Pharma | 27.33 Bn | 26.49 Bn | - | 0.15 |
| 10 | Cue Biopharma | 150.85 Mn | 133.43 Mn | - | -13.81 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 0.62 |
| Sep 30, 2025 | -2.43 |
| Jun 30, 2025 | -4.58 |
| Mar 31, 2025 | -6.55 |
| Dec 31, 2024 | -4.89 |
| Sep 30, 2024 | -5.64 |
| Jun 30, 2024 | -9.37 |
| Mar 31, 2024 | -11.41 |
| Dec 31, 2023 | -8.63 |
| Sep 30, 2023 | -7.85 |
| Jun 30, 2023 | -9.15 |
| Mar 31, 2023 | -9.21 |
| Dec 31, 2022 | -12.69 |
| Sep 30, 2022 | -9.46 |
| Jun 30, 2022 | -11.28 |
| Mar 31, 2022 | -13.18 |
| Dec 31, 2021 | -7.57 |
| Sep 30, 2021 | -13.70 |